ECSP034885A - QUINAZOLINE DERIVATIVES THAT PROMOTE THE RELEASE OF HORMONE PARTIROIDES - Google Patents

QUINAZOLINE DERIVATIVES THAT PROMOTE THE RELEASE OF HORMONE PARTIROIDES

Info

Publication number
ECSP034885A
ECSP034885A ECSP034885A ECSP034885A EC SP034885 A ECSP034885 A EC SP034885A EC SP034885 A ECSP034885 A EC SP034885A EC SP034885 A ECSP034885 A EC SP034885A
Authority
EC
Ecuador
Prior art keywords
promote
release
hormone
partiroides
quinazoline derivatives
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Rene Beerli
Sven Weiler
Leo Widler
Ruben Alberto Tommasi
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9916725&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ECSP034885(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of ECSP034885A publication Critical patent/ECSP034885A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

El uso de un copueto de la fórmula I: y en donde los símbolos son como se definen, o un éster farmacéuticamente aceptable y disociable, o sal de adición de ácido del mismo, para la preparación de un medicamento para promover la liberación de la hormona paratiroides, por ejemplo para prevenir o tratar condiciones óseas que estén asociadas con un mayor agotamiento o resorción de calcio, o en donde sea deseable el estímulo de la formación ósea y de la fijación de calcio.The use of a co-formula of the formula I: and wherein the symbols are as defined, or a pharmaceutically acceptable and dissociable ester, or acid addition salt thereof, for the preparation of a medicament to promote the release of the hormone parathyroid, for example to prevent or treat bone conditions that are associated with increased depletion or resorption of calcium, or where stimulation of bone formation and calcium fixation is desirable.

ECSP034885 2001-06-15 2003-12-08 QUINAZOLINE DERIVATIVES THAT PROMOTE THE RELEASE OF HORMONE PARTIROIDES ECSP034885A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0114702A GB0114702D0 (en) 2001-06-15 2001-06-15 Organic compounds

Publications (1)

Publication Number Publication Date
ECSP034885A true ECSP034885A (en) 2004-01-28

Family

ID=9916725

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP034885 ECSP034885A (en) 2001-06-15 2003-12-08 QUINAZOLINE DERIVATIVES THAT PROMOTE THE RELEASE OF HORMONE PARTIROIDES

Country Status (2)

Country Link
EC (1) ECSP034885A (en)
GB (1) GB0114702D0 (en)

Also Published As

Publication number Publication date
GB0114702D0 (en) 2001-08-08

Similar Documents

Publication Publication Date Title
CY1109767T1 (en) KINAZOLIN PRODUCTS PROMOTING THE release of parathyroid hormone
BR0316877A (en) Aryl-quinazoline / aryl-2-amino-phenyl methanone derivatives that promote parathyroid hormone release
HN2002000067A (en) INHIBITORS OF THE RHO - QUINASA.
UY26130A1 (en) COMPOUNDS TO TREAT OBESITY
WO2004084709A3 (en) Devices, systems, and methods to fixate tissue within the regions of body, such as the pharyngeal conduit
DE60029799D1 (en) COMPOUNDS, PROCESSES AND PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF CELL DAMAGE SUCH AS, FOR EXAMPLE, DAMAGE TO NERVE OR CANDLE TISSUE
BR0317888A (en) Human Growth Hormone Crystals and Processes for Preparing Them
ECSP034810A (en) DERETADOS HETEROCICLILALCOXI-, -ALQUILTIO- Y - ALQUILAMINOBENZAZOL SUCH AS LIGANDOS 5-HIDROXITRIPTAMINA-6
ECSP045353A (en) DERIVATIVES OF BENZOXAZINONA, ITS PREPARATION AND APPLICATION AS MEDICATIONS
BRPI0400214A (en) Pharmaceutical compositions and applications for reliable achievement of acceptable serum testosterone levels
ECSP045345A (en) TREATMENT OF GASTROPARESIA
MXPA03008635A (en) Cyano-substituted dihydropyrimidine compounds and their use to treat diseases.
PT1030667E (en) USES OF MIRTAZAPINE FOR THE MANUFACTURE OF A DRUG FOR THE TREATMENT OF SLEEP ONLY
UY26951A1 (en) DERIVATIVES OF OWN ACID
NO20014241D0 (en) C16-unsaturated FP-selective prostaglandin analogs
AR026655A1 (en) NEW STEROIDS WITH ANDROGENIC ACTIVITY AND ITS USE AS MALE ANTINCONCEPTIVES AND TO TREAT ANDROGENIC INSUFFICIENCY
ES2109561T3 (en) PROCEDURE FOR THE PURIFICATION OF WATER INTENDED FOR HUMAN CONSUMPTION.
ECSP034885A (en) QUINAZOLINE DERIVATIVES THAT PROMOTE THE RELEASE OF HORMONE PARTIROIDES
GEP201606538B (en) Preoperative treatment of post operative pain
BR0015781A (en) Pharmaceutical composition for treatment of diseases associated with decreased bone mass
PE20000423A1 (en) 2-METHYLPROPIONIC ACID DERIVATIVE AND THE PHARMACEUTICAL COMPOSITION CONTAINING IT
AR008695A1 (en) STABILIZED PHARMACEUTICAL COMPOSITIONS, BASED ON THE QUINUPRISTINE / DALPHOPRISTINE ASSOCIATION; PROCEDURE FOR PREPARING THEM, USE OF SUCH COMPOSITIONS AND USE OF METHESULPHONIC ACID OR OF HYDROCHLORIC ACID IN THE STABILIZATION OF SUCH COMPOSITIONS.
PE20011270A1 (en) [5-CYCLOPROPIL-1- (2-QUINOLON-5-IL) -1H-PIRAZOL-4-CARBONYL] GUANIDINE AS AN INHIBITOR OF THE SODIUM-HYDROGEN EXCHANGER TYPE 1 (NHE-1)
MD1585G2 (en) Biostimulating remedy
PE2298A1 (en) METHODS TO MINIMIZE LOSS OF OSEA